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Women, compared to men, are at higher risk for age-related macular degeneration 
(AMD), the leading cause of blindness in the elderly. The accumulation of dietary carotenoids, 
lutein (L) and zeaxanthin (Z) within the macula make up macular pigment and provide important 
protection to the retina. Macular pigment optical density (MPOD) gives a measure of macula 
pigment density.  MPOD has been shown to be influenced by fruit and vegetable L and Z and 
docosahexanoic acid (DHA, 22:6n-3), cold water marine fish being the dietary source.  A high 
MPOD may protect against AMD.  Intake of DHA by women is low (40-120 mg/d) and transfer 
of DHA during pregnancy to the fetus tends to deplete their stores.  To date, MPOD for pregnant 
women has not been evaluated.  We posed the question: “Is MPOD decreased during 
pregnancy?” MPOD was measured for 22 women using a macularmetrics densitometer at 18-23, 
24-26, 30, and 36-38 weeks of pregnancy.  Dietary information was collected using repeated 
food frequency questionnaires and 24-hour dietary recalls.   
  Women consuming a prenatal supplement containing DHA/fish oil during the third 
trimester tended to have a higher MPOD than those not supplementing (0.41 vs. 0.28).  While 
MPOD did not decrease from late second to third trimester in this small sample (MPOD, LSM ± 
SE: 0.34  0.03, 0.34  0.03, 0.35  0.04, 0.31 0.04), our data provided the opportunity to 
calculate that with a power of 80% and a significance of 0.05 a sample size of 121 participants is 
required to assess difference over pregnancy. MPOD was positively correlated with L and Z, the 
consumption of fruits and vegetables high in L and Z (p-value<0.02) and weekly seafood intake 
(p-value<0.01).  In conclusion, seafood as a source of DHA and dietary L and Z were associated 
vi 
 
with increased MPOD during pregnancy and prenatal supplements with DHA/fish oil may be 








Age related macular degeneration (AMD) is the leading cause of blindness amongst 
elderly individuals aged 60 years and older [1].  Degeneration of the retina, in particular the 
macula, causes blind spots and eliminates use of central vision.  These consequences are 
untreatable yet the causes for AMD are inconclusive.  Further, women have a higher prevalence 
of AMD than do men for reasons that are also unknown [2]. Herein it is speculated that life 
choices, such as pregnancy, may explain the higher risk for women.   
During pregnancy, the rate at which some nutrients are transferred from the mother to the 
developing fetus via the placenta is up-regulated during the third trimester when exponential 
growth of many organs occurs [3].  One of the nutrients which is preferentially transferred is 
docosohexaenoic acid (DHA, 22:6n-3) [4].  DHA is an important long chain polyunsaturated 
fatty acid (LCPUFA) that is abundant in the brain and the retina of the eye where it is 
concentrated in particular in the membranes and rod photoreceptors.  DHA is believed to provide 
proper maintenance and functionality for the retina especially as it interacts with two dietary 
components, the carotenoids lutein (L) and zeaxanthin (Z) [5].  However, the consumption of 
DHA during pregnancy is documented to be extremely low [6-8] and this may compromise the 
eye health of the mother. L and Z from dietary sources provide protection for the retina as they 
accumulate within the macula [9], functioning to assemble macular pigment (MP).  They also 
provide antioxidant functions by absorbing and filtering light [10].  High levels of MPOD are 
thought to provide a protective effect against AMD [11-13].  It is not known if MPOD 
modulation occurs during pregnancy when DHA is preferentially transferred from the maternal 
circulation to the developing fetus. This relationship between MPOD and pregnancy as it relates 





DHA‟s specific role in the eye is not completely understood.  However, Judge et. al [14]  
showed DHA during pregnancy to be important to infant visual acuity.  Infants born to women 
who were supplemented with DHA beginning in the second trimester of pregnancy had higher 
visual acuity scores at four months than infants of women consuming a placebo.  Evidence for 
DHA‟s effects on MPOD is very limited, and there is no research on DHA‟s effect on the 
mother‟s MPOD during pregnancy. However, some studies show promise for benefit of DHA in 
preventing AMD.  In the Nurses‟ Health Study and Health Professionals Follow up study from 
Cho et al. [15], researchers showed that individuals who consumed fish, a source of DHA, 
greater than 4 times per week were at decreased risk for AMD compared to individuals who 
consumed fish less than 3 times per month.  
With respect to L and Z, Johnson et al.[5] and Kopsell et al [16], have shown that by 
increasing L and Z in the diet, MPOD increases.  Others documented that dietary 
supplementation of L and Z increased serum and plasma response levels of L and Z [17-18].  
Studies on how these nutrients affect MPOD during pregnancy have not been conducted.  Based 
on the foregoing, it is hypothesized that MPOD will decrease during late pregnancy. 
Assumptions 
 It is assumed that participants will use the macular metrics machine correctly and all 
MPOD measurements from the studies will be taken and recorded correctly. 
Research Hypothesis 
MPOD will decrease in women from 18-23 to 36-38 weeks of pregnancy. 
Objectives  




2. To evaluate the relationship between diet and MPOD of pregnant women. 
Limitations 
1. Dietary intakes will be assessed using a 24 hour recall. Repeated recalls and probing 
during interviews will be used to increase validity. 





















Lipids are a group of compounds that are insoluble in water and soluble in fat, organic or 
hydrophobic solvents [19].  Lipids also have subcategories, ranging from extremely hydrophobic 
triglycerides, to saturated and unsaturated fats, essential fatty acids, steroids and the more water 
soluble phospholipids. These compounds are extremely variable in size and polarity, all serving 
as components of cell membranes by regulating the transfer of nutrients into and out of cells, and the 
fatty acids (FA) especially provide a concentrated source of energy.   
Fatty acids are biological lipids that are structurally composed of chains of unbranched 
hydrocarbon tails with a carboxylic acid group at one end and a methyl group at the other end 
[20]. This structure allows for one end of the FA to be polar or hydrophilic and the alternate end 
to be non-polar or hydrophobic making this end insoluble in water.  The hydrocarbon tails have 
diverse chain lengths usually of even numbered carbon atoms ranging from four to 24 carbons in 
length. FA differ from one another in the number and arrangement of double bonds along the 
hydrocarbon chain [20].  Structure is very important in identifying the FA.  The position of the 
first carbon of a double bond with respect to the methyl terminus allows for identification. The 
symbols “n” or “ω,” also known as „omega‟, identify the FA by designating the distance of the 
first double bond from the methyl end of the hydrocarbon chain [20].  In particular, the LCPUFA 
docosohexaenoic acid (22:6n-3), also known as DHA, has a chain length of 22 carbons with 6 
double bonds within the hydrocarbon tail and with the first double bond starting at the third 
carbon with respect to the methyl terminus.  The FAs are also classified as saturated or 




maximum number of double bonds that can be present in a chain is six. For example, FAs that 
have no double bonds on the hydrocarbon chain are designated „saturated‟, one double bond is 
„monounsaturated‟, and two or more double bonds, „polyunsaturated.‟ The preferential fatty acid 
types are found as cis conformations (both hydrogens are on same side of carbon chain) and are 
the fatty acids mainly present in the foods we eat. 
Essential Fatty Acids 
Lipids in our diet include the essential fatty acids (EFA) for the maintenance of 
functionality amongst tissue membranes [20].  There are two EFA, alpha linolenic acid (ALA, 
18:3n-3), an n- 3 FA, and linoleic acid (LA, 18:3n-6), an omega 6 FA.  Both of these EFA are 
necessary dietary components because they are required for growth and development as well as 
other physiological effects, but cannot be synthesized in the body. Burr and Burr developed the 
term EFA for “those fatty acids not synthesized in mammals and for which deficiencies could be 
reversed by dietary addition” [20].  After ingestion, EFAs are distributed amongst different types 
of lipids to supply energy and some will be metabolized into LCPUFA to be later integrated into 
structural lipids.  The liver is the main site for synthesis of EFA.  In the liver the n-3 and n-6 FAs 
undergo the same process of desaturation and elongation by enzymes to synthesize the LCPUFA.  
For example, the LCPUFA DHA and eicosapentanoic acid (EPA, C20:5n-3) can be 
endogenously derived from their EFA precursor ALA, and arachadonic acid (ARA) can be 
derived from its EFA, LA through a process of desaturation and elongation steps [20].  Dietary 
components of LCPUFA such as DHA are particularly important for humans, because of the 
extremely low endogenous biosynthetic conversion rate of the EFA to the LCPUFA.  This low 
conversion rate may be insufficient to meet the high demands of the CNS of the developing 




from the methyl end, thus n-3 and n-6 fatty acids are not synthesized [20].   The rate of ALA 
converted to DHA in infants is less than 1% [21-23].  Therefore, maternal intake of DHA needs 
to be sufficient to support the high demands of the fetus.   
 Figure 1 shows the conversion of the EFA precursors to their respective LCPUFA.  
Because both ALA and LA share the same enzymatic pathway, they compete with each other for 
the enzymes that will further metabolize them into the longer chains such as the derivates DHA, 
EPA, and ARA. Thus, a higher intake of omega-6 fatty acids, which is more commonly 
consumed within the American diet, limits the synthesis of ALA to DHA.    
 
 





DHA during Pregnancy 
During the third trimester of pregnancy, the fetus undergoes an exponential rate of 
growth and development and will require large amounts of ARA for growth and DHA for 
development of the central nervous system and retina [14, 25-26]. Thus, DHA and ARA are 
preferentially transferred from the mother to the fetus via the placenta. The syncytiotrophoblast 
of the placenta is a barrier site that separates the mother‟s microvillus membranous vasculature 
from the fetal basal membranous vasculature and it is at this site that nutrients can be exchanged 
between the mother and the fetus [27].  The placenta acquires free fatty acids such as DHA via 
passive diffusion along with the help of fatty acid-binding proteins (FABPs) that lie on the 
maternal side of the placenta and that transport fatty acids of chain lengths of 20 C or more, 
meeting fetal needs [22, 28].  
Because the fetal basal placenta membrane binds more fatty acids than the maternal 
membrane, greater amounts of  DHA are transferred to the developing fetus [14]. This 
continuous transfer across the placenta in effect drains the mother‟s stores of DHA and these 
stores may be difficult to replenish even after birth [29], jeopardizing maternal DHA stores and 
status [2, 30].  The mother must consume „adequate‟ amounts of DHA through exogenous 
sources instead of relying on the limited endogenous production to ensure that the developing 
fetus receives the required amounts for optimal development. 
Maternal Dietary DHA  
Currently, there is no recommended daily intake (RDI) for DHA in the United States 
[31]. However, for both pregnant and lactating women, experts suggest that approximately 200-
300 mg/d will support optimal fetal brain and eye development [32]. However, pregnant women 




On average, the typical pregnant woman in the US consumes only about 40–120 mg of DHA per 
day [33]. DHA consumption may be low because fatty cold water fish are not a part of the 
typical American diet [34]. One reason for the low consumption of fish may be the concern for 
the potential risk of mercury toxicity during pregnancy [31].  The main dietary sources of DHA 
are primarily oily fish such as salmon, tuna, sardines, mackerel, trout, bass, and halibut to name a 
few. Flaxseed oil and different types of nuts can contribute high amounts of dietary omega 3 
fatty acids of the 18 carbon species but relatively low amounts of DHA.   
The Retina: Anatomy and Physiology  
The retina is a highly vascularized tissue derived from the development of the neural 
plate during embryogenesis and is thus part of the central nervous system (CNS) [35]. The retina 
is responsible for the transformation of light energy into neural signals.  In order to complete this 
transformation, it is comprised of many different cell and neuronal layers that allow the human 
brain to interpret light signals.  For the purpose of this research, the focus will be on a few of 
these cells and layers. 
 
 




The cells that line the retina are called photoreceptors. A photoreceptor‟s main function is 
to absorb photons of light and thus initiate the visual cycle.  The photons of light provide 
external information and help to create electrical changes that signal the brain via a process 
called phototransduction [35]. There are two different types of photoreceptors: rods and cones.  
Rods are large in number and are responsible for vision in dim light [35]. They are found mainly 
in the peripheral region of the retina [37] rather than its most central part known as the fovea.  In 
contrast, cones which are smaller in number, are scarce in the peripheral region and are more 
abundant within the fovea [35].  Cones predominate in day light vision and are sensitive to color 
details because they are able to adjust quickly to various light levels [38].  
Photoreceptors have both an inner and outer segment.  It is the outer segments that 
capture photons and generate electrical signals [35]. Photoreceptor outer segment (POS) tips are 
the most vulnerable to every day light energy. Rod outer segments (ROS) are comprised of lipid 
filled discs that pile amongst each other.  The membranes in each disc concentrate both DHA 
and rhodopsin, a visual pigmented protein that absorbs photons [35].  The absorption of light is 
extremely damaging to ROS as shown by their high metabolic activity and short lifespan [39].  
Light damaged ROS tips accumulate waste products such as oxidized lipids, light damaged 
proteins and free radicals [39]. ROS must shed these tips to maintain excitability [39] and to 
rapidly regenerate after they have absorbed light [10, 39-40].  Therefore, the tips of the ROS are 
shed and phagocytized within the retinal pigment epithelium layer (RPE) [35].  
The RPE is a layer of pigmented cells that has a variety of functions, however, for the 
purpose of this research, two functions that will be highlighted are its role in the phagocytosis of 
shed ROS discs and the absorption of scattered light [38].  As seen in Figure 2, the RPE‟s apical 




with photoreceptors while its basal membrane faces the choroid [35, 38].  The RPE contains 
phagosomes, small compartments that digest damaged ROS which are released from the 
photoreceptor and accumulate for life within the Bruch‟s membrane [35].  As the basal side of 
the POS becomes phagocytized, the apical side of the photoreceptors rebuild themselves and the 
RPE will conserve and recycle important nutrients such as DHA and retinal back to the 
photoreceptors.  This process allows for restored excitability and the maintenance of vision [39].  
This is important to note because if DHA is most commonly found in the rod outer segments, 
which are constantly being regenerated, in addition to some recycling of DHA from the RPE 
back to the photoreceptors, DHA intake during pregnancy may need to be increased to ensure 
proper functioning of the retina.   
 The Bruch‟s membrane is located just above the choroid capillaries. This membrane 
allows for the exchange of nutrients from the choroid and catabolites from the retina [38].  The 
choroid, although not part of the retina, helps to absorb any additional scattered light, in 
particular the light that diffuses through the RPE.  As currently understood, the photoreceptors, 
RPE, Bruch‟s membrane and choroid each play an intricate role in the development of AMD.  
As an individual ages, destructed lipids from the ROS accumulate in the Bruch‟s 
membrane impeding for the exchange of metabolites, in particular water and catabolites, from 
both the retina and choroid [38].  As a result, water begins to accumulate between the RPE and 
Bruch‟s membrane causing detachment of the retina [38].  Thus, nutrients from the choroid will 
not be delivered to the retina and as a result the RPE and photoreceptors deteriorate resulting in 
visual loss [38]. Additionally, the loss of nutrients causes the Bruch‟s membrane to develop new 
vessels in its search for alternative  nutrients [38].  Unfortunately, this event is extremely 




loss [38].  However, to date, the initiating event in AMD development remains elusive and 
undefined. 
Macular Pigment Optical Density (MPOD) 
Macular pigment optical density (MPOD) is the measure of retinal pigment, in particular 
the accumulation of lutein (L) and zeaxanthin (Z) within the macula.  Macular pigment (MP) is 
comprised of oxygenated xanthophylls L and Z that function as non pro-vitamin A precursors. L 
and Z accumulate within photoreceptor axons [9] and act as free radical scavengers. MP also 
absorbs and appreciable amount of light thus preventing large amounts of light from reaching 
sensitive parts of the retina, such as the RPE [11, 41], by absorbing and filtering light before it 
reaches photoreceptors [10, 42].  
Snodderly et al. [43], showed that L and Z are concentrated in the inner layers of the 
central retina, the macula, in particular the fovea.  The further the distance from the fovea, the 
more dispersed L and Z become [9]. The peripheral region of the retina contains limited L and Z, 
while ROS which contain large amounts of DHA, are comprised of about 25% L and Z [9]. L 
and Z absorb a maximum of 445 nm light through their polyphenol chain structure.  Light waves 
of 445 nm, known as blue light is considered the most energetic portion of the visible light 
spectrum and can cause the most damage to the retina [44].  
Therefore, MPOD increases have been reported to mirror increased consumption of L 
and Z. Thus, MPOD has a significant and positive relationship with L and Z concentration 
amounts [9].  Berendschot et al. [42], demonstrated this relationship through supplementation 
with L.  In that study, eight men were given 10 mg supplements of L for 12 weeks.  There were 
significant increases in MPOD as early as week 4 of supplementation.  Continued 




only did individuals show a significant increase in MPOD with supplementation, they also 
showed a decrease in MPOD four weeks after supplementation was terminated and MPOD 
returned to baseline values.    
Supplementation was also evaluated in a study conducted by Kopsell et al [16]. They 
supplemented two groups of 10 males and females with spinach with a low concentration of L 
and Z or spinach yielding a high concentration of L and Z.  MPOD was evaluated at baseline and 
subjects were asked to consume his/her spinach meal 5 times per week for 12 weeks. MPOD was 
measured for the second time at the twelfth week.  MPOD for consumers of the spinach with 
high L and Z concentrations were higher during the twelfth week compared to baseline, while 
MPOD for subjects who consumed spinach with a low concentration of L and Z were not 
different at week 12 compared to baseline. Thus Kopsell et al. showed that MPOD can be 
increased by consumption of food high in L and Z.   
In another study Landrum et al [45] showed that MPOD was influenced by the 
supplementation of 30 mg of L.  In  that study  two male subjects, aged 41 and 52, were given a 
30 mg dose of L esters each day for 140 days and MPOD was measured before, during and post 
supplementation.  Subjects also had blood serum L levels measured before, during and after 
supplementation.  There was a dramatic rise in MPOD 20-40 days after supplementation and 
MPOD continued to rise 40 to 50 days after supplementation was discontinued.  The continued 
rise after supplementation was interpreted to be due to the high dose of L and the retina‟s 
capacity to store L.  Landrum et al suggested a potential benefit of increased MPOD with L 






Lutein and Zeaxanthin 
There are many different stereoisomers of the xanthophylls L and Z.  However, within 
the retina, the stereoisomer that is most pronounced  is lutein, (3R,3‟R,6‟R) Beta,E-carotene-
3,3‟-diol [41]. Z has three different stereoisomer forms [41]. Z is abundantly found in all three of 
its forms which include 3R, 3‟R and 3R, 3‟S [41]. Therefore, dietary practices may be influenced 
by noting the significance between L and Z and MPOD. 
L and Z are derived from dietary components and are found most abundantly protein 
bound within chromoplasts and petals of various plant sources [9]. Sources of high levels of L 
and Z are colorful yellow, orange, and green plants that include, but are not limited to, kale, 
spinach, corn, orange peppers and honeydew [9, 41].  Within plants, L and Z also function as 
antioxidants and are believed to act as antioxidants for the retina‟s rich light and oxygenated 
environment [11, 41, 46]. In addition, egg yolks, although lower in L than spinach, provide a 
high bioavaialable source of L which rapidly increase L concentration in the blood [9]. 
There is no recommended daily allowance (RDA) for L, however, positive dietary effects 
of L on MPOD have been shown at levels of 6-10 mg/d [46]. On average, individuals consume 
about .8 to 4 mg of both L and Z together daily [9]. L and Z are fat soluble substances and when 
consumed they are transported via lipoproteins [9, 41] and accumulate in adipose tissue [9]. High 
density lipoproteins (HDL) are the main transporters of L and Z [9]. Research suggests that HDL 
preferentially transports L and Z to the retina because the retina favors HDL uptake [9]. L and Z 
are deposited in the retina via HDL at levels of 0.1 to 1 mM [9, 41].  
DHA in the Retina 
 DHA is a key nutrient found within retinal membranes and in particular the rod outer 




DHA is selectively transported to photoreceptor membranes and these membranes accumulate 
the highest concentration of DHA of any cells in the human body [23].  Although DHA‟s role 
within the retina is not completely understood, what we do know is that DHA helps to promote 
photoreceptor survival through the renewal process. DHA is highly accumulated within lipid 
filled discs of the ROS from the photoreceptors.  Figure 3 [48], shows the transport of DHA into 
the photoreceptor cell [48]. For DHA to get to the photoreceptors it must first be ingested and 
esterfied into phospholipids packaged from the liver.  DHA filled phospholipids will then be 
transported through the blood stream via lipoproteins that pass through the choroid layer to be 
deposited into the RPE.  A short loop shunts the DHA from the RPE into the photoreceptor inner 
segment, a site of rebuilding for the photoreceptors.  As ROS tips become phagocytized, DHA 
moves from the inner segments of the photoreceptors into the ROS via the connecting cilium 
between the inner and outer segments [48]. DHA may also be taken up from the shedded ROS 
that accumulate in the RPE and can be transported back to the inner segments via a short loop; 
thus, DHA has the ability to be both conserved and recycled within the retina [49].  Therefore, 
the RPE supports photoreceptors by supplying them with DHA, a vital relationship in the 
function and survival of photoreceptors [50].  Apoptosis or extensive damage to the RPE may 












Figure 3. The transport of DHA from the diet into the photoreceptor cell. Reproduced from [48]. 










DHA Offers Protection to the Retina  
Every cell in the human body requires signals for survival.  These signals are referred to 
as trophic factors (TF).  In the absence of TF, cells undergo programmed cell death via 
interactions between pro-apoptotic and anti-apoptotic proteins. The mechanisms by which DHA 
protects the retina remains unknown.  It may not be DHA per se, but rather, TF effects of DHA 
and neuroprotectin derivatives of DHA from both the RPE and photoreceptor cells that may 
respond to oxidative stress [48].  DHA has been demonstrated to impede photoreceptor apoptosis 
by acting as a TF [51]. Cell death occurs when the outer mitochondrial membrane becomes 
penetrated [52].  Politi et al [53] showed that addition of DHA and glial derived neurotrophic 
factor (GDNF) either simultaneously or individually preserved the mitochondria, decreasing 
photoreceptor apoptosis. GDNF and DHA also act as a TF [53]. Specifically, GDNF protects rat 
retinal photoreceptors from apoptosis progression in vitro by 70% as compared to controls.  The 
addition of both DHA and GDNF on photoreceptor cells was dramatic. The combination of the 
two enhanced photoreceptor cell survival more than either DHA or GDNF alone.   
Bazan et al [48] demonstrated that neuroprotectin D1 (NPD1), a DHA derived mediator, 
maintained the survival of the RPE.  During a time of oxidative stress, DHA is a target of lipid 
peroxidation.  However, NPD1 helps to protect retinal layers from oxidative damage.  NPD1 acts 
within the RPE to protect photoreceptors by inhibiting cell death and oxidative stress mediated 
proinflammatory genes [48].  NPD1 may do this by up-regulating protective Bcl-2 proteins. Bcl-
2 is the prototype for a family of genes and proteins that govern mitochondrial outer membrane 
permeabilization.  There are two types of Bcl-2 proteins, pro-apoptotic Bcl-2 proteins such as 
Bax and Bad and anti-apoptotic proteins Bcl-2 proper and Bcl-w to name a few.  Oxidative stress 




anti-apoptotic Bcl-2 proteins via NPD1.  Thus, stress factors become unavailable to the outer 
mitochondrial outer membrane [52].                                                                                                                                                 
Rotstein et al [51], also showed the protective effects of DHA on oxidative stress [54]. 
These investigators conducted a cell culture study in which oxidative stress in the form of  
paraquat was presented to rat retinal neurons with or without DHA for 3 days [54].  In neurons 
without DHA, there was penetration of oxidative stress to the mitochondrial membrane; thus, 
oxidative stress was not prevented and neuronal apoptosis occurred.  However, neurons exposed 
to paraquat and treated with DHA had an up-regulation of Bcl-2 molecules and protected cells 
against Bax or pro-apoptotic expression preserving the mitochondrial membrane.  Apoptosis of 
photoreceptor cells was prevented by the addition of DHA.  It was demonstrated that DHA 
helped to protect penetration of the mitochondrial layer by expression of mechanisms such as 
anti-apoptotic Bcl-2 proteins, protecting photoreceptor cells from apoptosis.  Thus, although the 
mechanism(s) of DHA in the protection for the retina is not completely understood, both DHA 
derivatives and the up-regulation of Bcl-2 neurons may offer this protection.  In turn, the 
maintenance of a healthy retina is dependent on the survival and longevity of photoreceptors in 
conjunction with the RPE.   
Importance of DHA during Infant Development 
The benefits of DHA within the retina are most commonly noticed in infant studies. 
Research suggests that if DHA status is insufficient, retinal function of the fetus may endure 
damage [29] and may become vulnerable to visual and neural abnormalities [55].  DHA aids in 
fetal eye development and approximately 60% of DHA derived from the mother during 
pregnancy will accumulate within the retina of the fetus [56].  In a randomized, longitudinal, 




either a placebo cereal bar or a DHA supplemented cereal bar and were asked to consume the bar 
three, five, or seven times per week, during 24 weeks of pregnancy to delivery.  Infants of 
mothers who were supplemented with the cereal bars containing DHA had higher acuity card 
procedure visual acuity scores at four months of age compared to controls [23], validating a 
deviation from subnormal sensory maturation experienced by infants who lacked DHA within 
the photoreceptors of the membrane.  
Carlson et al. [25] showed that development of the retina via DHA largely affects visual 
acuity.  Carlson et al. supplemented preterm infants with marine-oil resulting in an improved 
infant DHA status and visual acuity [25].  Preterm infants at approximately 3 weeks of age were 
divided into four different groups which consisted of: 1. a commercial preterm formula, 2. a 
commercial term formula, 3. a marine oil-supplemented preterm formula or, 4. a marine oil-
supplemented term formula.  There were significant positive effects on visual acuity of the 
preterm infants fed either the marine oil supplemented preterm or term formulas at 2 months and 
four months of age [25].  Makrides et al. [57] showed that infants fed breast milk (which 
contains DHA) scored better on visual and developmental tests than non-DHA containing 
formula fed infants.  Together the study results show that with increased DHA consumption 
either during pregnancy or breastfeeding, infant retinal physiology and visual acuity improves 
[23, 25, 57].  
The impact of DHA depletion during pregnancy [4] on a mother‟s retinal health has yet 
to be evaluated.  Maternal stores of DHA are drained to provide an adequate supply of DHA to 
the fetus.  This transfer is crucial during the last trimester when fetal development of the brain 
and retina is exacerbated [58].  Further, this elevated fetal need may pull DHA from sources such 




review of literature, pregnancy may be related to a decreased MPOD.  DHA interacts with 
photoreceptors which have been documented to play a large role in the maintenance of retinal 
health.  Low DHA status may be inefficient in repairing damaged photoreceptors and may 
contribute to increased oxidation and damage to the retina. 
DHA May Modulate MPOD 
The cells and layers of the retina work together intricately.  Rapp et al [59], showed that 
not only do L and Z accumulate within the macula, they also exist within ROS membranes and 
potentially offer antioxidant protection. The protection that L and Z may provide to the ROS is 
likely extremely essential to physiological maintenance, underscored by the fact that POS are 
targets for oxidative stress because of their high LCPUFA content [60].  These inter-relationships 
are found throughout the retina.  DHA may influence blood and macula accumulation of L [5]. 
Sanders et al [47], showed that supplementation of 20 g of DHA plus EPA can increase HDL 
levels [47]. HDL is a major transporter for L and Z.  It is hypothesized that by increasing DHA, 
the delivery of dietary L and Z to the macula may also be increased and therefore potentially 
influence MPOD. However, Huang et al [61] found that the addition of n-3 LCPUFA to oral 
supplementation of L/Z in elderly subjects with AMD did not change the serum levels of L and 
Z.  This could have been due to L concentrations and the L formulation of the supplementation.  
It is hypothesized that a higher content of DHA will help to alleviate large amounts of 
oxidative stress on the eye secondary to one‟s environment possibly resulting in a higher MPOD.  
As mentioned earlier, pregnant mothers preferentially supply the fetus with DHA for adequate 
development of the retina and brain.  Because the fetus receives DHA from the mother, mothers 
who do not get enough DHA from the diet or via DHA supplementation may lack DHA for 




Therefore, it is hypothesized that the ingestion of DHA may provide protection against oxidative 
stress.  Thus, the larger burden the pregnant mother will endure with less DHA will negatively 
affect her MPOD.  As a result, a prediction is that less DHA will result in a lower MPOD.  This 
prediction is similar to Johnson et al [5] that showed an increase in central MPOD in elderly 
women with DHA supplementation alone.  
Age-Related Macular Degeneration and DHA 
Maximizing MPOD alleviates the amount of blue light reaching the retina and offers a 
reduction in the amount of free oxygen radicals within the retina.  L and Z‟s antioxidant abilities 
are instrumental in this protection [1]. Thus, L and Z probably protect  against the development 
of eye diseases such as AMD [11].  
In the United States (U.S), AMD is the leading cause of eye disease amongst senior 
citizens (60+) [1].  With damage to the macula there is visual disability or even vision loss [1, 
15]. Usually, vision is not completely lost, but central vision may become depleted leaving only 
peripheral vision [62]. There are two types of AMD:  Wet AMD and Dry AMD. The dry form of 
AMD is most common and is usually characterized by the presence of a soft drusen between the 
RPE and Bruch‟s membrane [63]. The wet form however, represents the formation of new blood 
vessels from beneath the retina in search of the choroidal layer [63].  Both types of AMD cause 
central vision loss.   
Currently, there is no cure or preventative method for AMD for it has no known source of 
onset. Key pathogenic processes of AMD are oxygenic, inflammatory, age and sex related 
factors (the risk of AMD increases with age and is more prevalent among elderly women than 
men [2]) and retinal damage [64]. Thus, DHA has the potential to influence factors responsible 




systematic review Chong et al [65] showed that consumption of fish two or more times per week 
and rich sources of omega-3 fatty acids were associated with a reduced risk for AMD.  The 
results of Cho et al [15] were consistent with this finding.  In this prospective cohort follow up 
study from the Nurses‟ Health Study and the Health Professional, Cho et al. reported that fish 
intake was inversely related to the risk of AMD and that individuals 50 years and older who ate 
fish greater than four times per week, had a lower risk of AMD than individuals who ate fish less 
than 3 times per month. Similarly, Augood et al [66] reported that oily fish consumption at least 
once per week compared with less than once per week was associated with halving the odds ratio 
(OR) for AMD.  Participants aged 65 years and older had their fundus images graded and 
classified into stages of AMD (late vs. early) and fish intake and risk factors were assessed by 
using a food frequency and risk factor questionnaires.  Augood et al found a significant 
association between oily fish consumption and/or fish with higher amounts of DHA and EPA 
than non oily fish in decreasing the OR of AMD [66]. 
 Currently, no large randomized clinical controlled trials that evaluate n-3 fatty acids and 
fish intake in the primary prevention of AMD exist [65].  A prospective cohort study conducted 
by Seddon et al [67] found no effect in the progression of AMD when subjects had an increased 
fish intake.  In that trial, only individuals who were in the below median consumption group for 
linolenic acid , showed protective effects against the progression of AMD.   
Thus, because the onset and treatment of AMD is still unknown, health precautions such 
as consuming recommended amounts of 2 to 3 servings of fish weekly, wearing sun glasses, 
eating a diet high in L and Z, and avoiding cigarette smoke, should be practiced and may help 
prevent the detrimental disabling effects of AMD.  In sum, there are limited observational and 




with the progression of AMD and its effects on MPOD.  There are no known studies noted 






























Upon the approval of the protocol by the Institutional Review Board of Louisiana State 
University‟s (LSU) Agricultural Center (AgCenter) adult pregnant women (n=24) who were 
residents, students, faculty and staff of LSU, East Baton Rouge Parish or surrounding parishes 
and 18- 40 years old were recruited to participate in this study.  Additionally, these women were 
determined to be appropriate participants because they did not smoke or drink alcohol, as well as 
reported no diagnosis of eye disease.  In order to recruit participants, flyers were distributed on 
the LSU campus and recruitment occurred through the AgCenter website.  Public 
announcements were also made at Women Infant and Children (WIC) clinics and birthing 
classes at community centers for women and at hospitals.  Women agreed to visit the Maternal 
and Infant Nutrition Laboratory, Knapp Hall at LSU four times during their pregnancy to 
participate in the measurement of macular pigment.  During each visit they also completed a 
health history form questionnaire and a 24-hour dietary recall (NDSR) to assess the foods they 
had eaten.  
Study Design 
 Consenting women were required to make four visits during pregnancy at 18-23 weeks, 
24-26 weeks, 30 weeks, and 36-38 weeks to the LSU Human Nutrition Assessment Laboratory, 
Knapp Hall.  These weeks encompass the period in which DHA transfer from the mother to the 
developing fetus is most dramatic.  The women completed a dietary survey health history form at 
each visit (see appendix).  Health History Form #1 (Appendix A) was used at each participant‟s 




history of eye disease, presence of high blood pressure or cholesterol, nutrient supplementation, 
location where most foods were eaten, the most commonly eaten fruits and vegetables, the 
frequency for consumption of fruits and vegetables, amount and type of seafood consumed, and 
barriers for not consuming some fruits or vegetables and fish.  Subjects were interviewed with 






 visits to document new diagnoses 
during pregnancy, such as gestational diabetes mellitus.   
First Visit: 
 Height was measured using a stadiometer.  Weight and BMI were determined using a 
SECA scale.   
 The Macularmetrics instructional video was viewed by the subject for instruction on the 
method for recording null flicker matches.  For example, participants were taught how to 
rotate the subject‟s knob at a standard speed, find the point at which the flicker stops and 
select that point by pressing a red button. All questions about the use of the machine were 
answered before the subject began her trial.    
 The Eye guard was sanitized before each participant used the machine. The participant 
then completed 10 trials in two stimuli (2 and 5). Stimuli 2 and 5 are the degrees of 
eccentricity that test the direct measurement of the amount of MPOD in the eye.  
 Dietary intake via a 24-hour recall was completed either in person or via the telephone, 
depending on the participant‟s personal schedule.  The University of Minnesota 2008-
2009 Nutrition Data System for Research program (NDSR) was used to quantify the 




 The next appointment during the 24-26th week of pregnancy was scheduled and a 
reminder e-mail was sent out. 
 Visits 2, 3 and 4: 
 Participants were reminded in advance via telephone call or email about the appointment 
day and time. 
 Participants came to the lab, completed Health History Form # 2 and had their weight 
measured and BMI calculated. 
 The women were asked if they needed to be reminded about proper Macularmetrics 
machine use. 
 The eye guard was sanitized and the participant performed 10 trials in each stimuli. 
 Assessment of usual nutrient intake was assessed by conducting a 24-hour dietary recall 
either in person or over the phone. Once again, this assessment format was dependent 
upon the participant‟s personal preference and the University of Minnesota 2009-NDSR 
Nutrition Data System for Research program was used. 
 Appropriate appointment time was scheduled in advance for the follow up visit(s). 
 After the second visit, a dietary assessment based on two dietary recalls was provided to 
participants for personal use to guide in the selection of foods for optimal health during 
pregnancy.  Macronutrients as well as micronutrients from recalls were compared to 
recommendations and this information was shared with the individuals.  LSU AgCenter 




women were also provided to each participant. Women were instructed on how to 
navigate MyPyramid.gov for pregnant women as well. DHA was not mentioned in the 
individual‟s reports in order to avoid dietary changes. 
Measurement of MPOD 
 The Macularmetrics Densitometer machine was first calibrated in a dimly lit room to 
adjust LED blue and green light according to the manufacturer‟s instructions.  
 Measurement of MPOD was taken for the right eye of each participant. 
 Subjects were instructed to find the optimal flicker frequency (OFF) while the evaluator 
increased or decreased the frequency in increments of 1 Hz until the null flicker was 
perceived.  „OFF‟ was adjusted for each participant during each visit to control the flicker 
rate using the participant‟s right eye.   
 Participants increased the frequency by turning the subject knob until the flicker stopped.  
Measurements were documented by the evaluator and the subject knob was then 
readjusted so that an area of “null” flicker was no longer perceived.   
 This process was repeated for a total of ten trials in stimulus #2 and stimulus #5. Values 
were recorded.  Any outliers were deleted and the participant was asked to complete 
additional readings (± 500). Note: Each subject was allowed to move away from the 






Assessment of MPOD Using the Macular Metrics Densitometer Machine  
 The instrument that was employed to evaluate MPOD eccentricity is the „Macular 
Metrics Densitometer.‟  MPOD was measured in the right eye only by heterochromatic flicker 
photometry. The machine was calibrated at each visit.  Such calibration allowed participants to 
see a visual target with an even mixture of both green and blue light and was adjusted so that no 
change in brightness of the target is encountered [68]. The luminance of the green light is 550 
nm and blue light is 460 nm and was in the yoked position, meaning as one color increases, the 
other decreases and vice versa [68].  Blue light is the only light absorbed by the MP and the 
participant will also see a flicker based on the variation of blue light [10].  Blue light is necessary 
because it allows for only long (L) and medium (M) cones to be active and for rods and sensitive 
(S) cones to become inactive.  Light needs to fall on the fovea to allow for distinct vision. 
Therefore, sensitive S-cones need to be saturated with the blue light before any flickering may be 
observed [10].  Variations between readings were controlled for by adjusting the flicker rate until 
a rate of no flicker was observed by the participant [68].  Testing then began. The densitometer 
used a reference location at 7 degrees (stimulus #5) in which the participant had to fixate on a red 
light that helped to map MP spatial profile using a parafoveal target [10, 68].  A 0 .5 degrees 
retinal loci (stimulus #2) that accounted for a 1 degree diameter was used because this is the 
location at which the fovea may be measured where high concentrations of L and Z are present.  
Thus, at 0.5 degrees, a representation of MP may be measured [68], and gave the most direct 
measurement of MP.  The women were asked to adjust the amount of blue light by rotating the 
subject‟s knob in order to observe a point at which there was no flicker.  The amount of blue 






Data were analyzed using JMP 8.0 (SAS institute, Cary, NC).  The relationship between 
MPOD and DHA and lutein and zeaxanthin were evaluated using Pearson correlations.  
Information pertaining to DHA and lutein and zeaxanthin were obtained from dietary survey 
health history forms given to participants at each visit (Appendix A) in which women estimated 
weekly, monthly or yearly fruits and vegetables and seafood intake. 
  Differences at weeks 18-23, 24, 30, 36-38 during pregnancy were determined using the 
least significance mean (LSM).  Analysis of variance (ANOVA) was used to evaluate group 
differences in MPOD, dietary, supplementation and total (diet + supplement) DHA  between 
mothers who supplement with a DHA containing prenatal supplement (± DHA) or other 
DHA/fish oil supplements and mothers who did not supplement with DHA to determine the 
difference between the groups (T-test).  
Repeated-measures analysis of covariance (ANCOVA) was used to evaluate MPOD 
while controlling for covariates that have been shown to impact MPOD (lutein and zeaxanthin, 


















 Long chain polyunsaturated fatty acid, docosahexaenoic acid (DHA, 22:6n-3), accretion 
is particularly important for the developing fetus to ensure proper retinal and brain development 
and functional activity [69]. Thus, DHA from maternal stores is transferred across the placenta 
and becomes indispensible in the last trimester of pregnancy [58].  As a result, maternal DHA 
stores become drained and may leave a mother at risk for insufficient DHA for her own retinal 
health. 
 As women age, risk for age-related macular degeneration (AMD) increases.  The reason 
why women are at a higher risk than men is unknown.  However, research shows that dietary 
carotenoids lutein and zeaxanthin [12-13] (which accumulate and provide a foundation for 
macular pigment optical density, MPOD) and fish consumption [15, 65-66] are associated with a 
lower risk of AMD.  Johnson et al also showed that DHA supplementation may increase central 
MPOD in elderly women [5].  Studies to evaluate DHA status during pregnancy and its 
relationship with MPOD have not been reported. Therefore, the purpose of the current study was 
to evaluate if MPOD decreases in the last half of pregnancy.  
Methods 
Subjects and Study Design 
 Twenty-four pregnant women (18-24 weeks) of gestation, 18-40 years of age and who 
did not drink or smoke were recruited from Louisiana State University (LSU) campus through a 
local newspaper ad and from local clinics by public announcement, word of mouth, and by 




Each woman that expressed interest by responding to the request for study participants was sent 
an informational brochure via e-mail or was contacted by telephone.  Women who had eye 
disease or history of disease such as blindness were excluded from the study.  Women who met 
the inclusion criteria and agreed to participate signed an informed consent form which had been 
approved by the Louisiana State University AgCenter Institutional Review Board (IRB).  By 
consenting women agreed to come into the Maternal & Infant Nutrition Laboratory at LSU and 
have their MPOD measured using a macularmetrics densitometer machine at weeks 18-23, 24-
26, 30, 36-38 during pregnancy, complete a dietary questionnaire at each visit, and participate in  
a 24-hour dietary recall. 
 Respondents visited the Maternal & Infant Nutrition Laboratory, Knapp Hall at LSU 
during set appointments at time of recruitment for weeks 18-23, 24-26, 30, 36-38 weeks of 
pregnancy.  Appointments were made in advance and participants were reminded via email or 
telephone a day before each visit about their selected appointment time.  The first visit for each 
woman was the longest and ranged from an hour to an hour and a half.  The subsequent visits 
ranged from thirty minutes to an hour to complete all requirements.  Information pertaining to 
lutein and zeaxanthin and DHA were obtained from dietary survey health history forms given to 
participants at each visit (Appendix A) in which women estimated weekly, monthly or yearly 
fruits and vegetables and seafood intake.  If women gave a range for intakes, the two numbers 
were averaged and the mean value used in analyses.  To distinguish fruits and vegetables high in 
lutein and zeaxanthin and seafood high in DHA, documents listing fruits and vegetables high in 
lutein and zeaxanthin and high in DHA were used (Appendix B).  After densitometer trials were 
completed 24-hour recalls were conducted using The University of Minnesota 2009 Nutrition 




Determination of MPOD 
 Ten trials in each stimuli (2 and 5) were achieved if the participant‟s luminance values 
varied no more than ± 500 log.  If luminance values varied for a trial the trial was repeated and 
the new value was recorded.  Values from each stimulus were recorded manually and at the end 
of each visit were recorded electronically. From this electronic data base, stimuli values were 
used to calculate MPOD.  
MPOD=   log(base 10) [ blue radiance/green radiance  for target 2] - log(base 10) [blue 
radiance/green radiance for target 5] 
Statistical Analyses 
 Data were analyzed using JMP 8.0 (SAS Institute, Cary, NC).  The relationship between 
MPOD and dietary DHA and dietary lutein and zeaxanthin were evaluated using Pearson 
correlations.   
 Differences at weeks 18-23, 24, 30, 36-38 during pregnancy were determined using the 
least significance mean (LSM).  Analysis of variance (ANOVA) was used to determine group 
differences in MPOD and dietary, supplementation and total (dietary intake + supplement) DHA 
intake between mothers who supplement with a DHA or fish oil containing prenatal supplement 
(± DHA) or other DHA/fish oil supplements and mothers who did not consume prenatal 
supplements with DHA or fish oil.  A woman was considered to be supplementing if she 
consumed prenatal vitamins with DHA or fish oil before her initial visit (18-23 weeks) and 
continued to supplement at least up to her second visit (24-26 weeks).  ANOVA was used to 
evaluate group differences in MPOD, dietary DHA intake, prenatal DHA/fish oil 




who met expert group DHA recommendations of 300 mg or more of DHA [32] and those who 
did not meet that recommendation. 
 Repeated measures analysis of covariance (ANCOVA) was used to evaluate MPOD 
while controlling for covariates. Covariates were those characteristics that can be associated with 
change in MPOD: lutein and zeaxanthin, dietary, supplement and total DHA [5, 16].  Level of 
significance was set at p≤0.05.   
Results 
Subjects 
A total of 24 participants were recruited for assessment of MPOD [18-23 weeks (n=20), 
24-26 weeks (n=22), 30 weeks (n=21), 36-38 weeks (n=18)] during pregnancy. Of the 24 
participants recruited one participant withdrew citing permanent bed rest required by her 
physician. A second participant‟s data were excluded from analysis because MPOD values 
indicated a probable technical misunderstanding of equipment use.  Thus, data presented in this 
study are for 22 women.  Women were on average 29 years of age, predominately white, and 
delivered one child previously (Table 1). 
Table 1. Characteristics of participants 
Characteristics Women (n=22) 
Age (years) 29.32 ± 5.06 
Ethnicity (%) 
 
White  (81%) 
Black  (4.5%) 













   While all women were consented and scheduled for MPOD assessments at four time 
points, there were four subjects with missing data for reasons due to: late recruitment (n=2), 
move to out-of-state (n=1), and premature delivery (n=1).  One participant was diagnosed with 
gestational diabetes mellitus (GDM) while another participant began the study with type 2 
diabetes.  Participants with GDM and type 2 diabetes remain in the final data analysis because 
MPOD was not significantly different from other participants.  Currently, two women have yet to 
complete assessments. 
Diet 
 There were no differences between time points (18-23 to 36-38 weeks) for the following: 
dietary lutein + zeaxanthin; energy; dietary, prenatal and total DHA (dietary + supplement) 
(Table 2).   
Table 2. Diet and Prenatal Supplements with DHA/fish oil for Study Participants 













296 ± 443 445  ± 802 186  ± 173 175  ± 186 
Dietary DHA 
(mg) 
146  ± 399 299  ± 802 58  ± 61 72  ± 73 
Prenatal DHA 
(mg) 




1797  ± 1963 1371  ± 1916 1719  ± 1328 1453  ± 1340 




Supplementing vs. Not Supplementing with a Prenatal Containing DHA/Fish Oil 
 In total, 11 women supplemented with a prenatal containing DHA or fish oil and 11 
women supplemented with a prenatal not containing DHA or fish oil.  Two women were 
consuming prenatals with DHA or fish oil during their first visit but discontinued 
supplementation for the remaining three visits and thus were categorized as not supplementing 
with prenatals.  Of the 11 women supplementing with prenatals containing DHA or fish oil 
consumption on average was 255 ± 76 mg of DHA/day from prenatals.  Women consuming 
prenatals containing DHA or fish oil versus women not consuming prenatals with DHA or fish 
oil consumed the same amount of dietary DHA (165 ± 220; 114 ± 225 mg DHA/day, p=0.60).  
Women supplementing with prenatals containing DHA or fish oil consumed 421 ± 208 mg 
DHA/day from total DHA (dietary + supplement), whereas those not supplementing with a 
prenatal containing DHA or fish oil consumed significantly less (114 ± 225, p≤0.01).     
MPOD 
 There was no change in MPOD over the course of pregnancy when controlling for lutein 
+ zeaxanthin and total DHA (dietary + supplement) (Means ± SD: 0.34  0.03, 0.34  0.03, 0.35  






18-23 weeks 24-26 weeks 30 weeks 36-38 weeks
  
Figure 4. Macular Pigment Optical Density (MPOD) over time 
Means ± SD. MPOD values over time. Superscript above each time indicates no significant 







MPOD , Dietary and Supplemental Intake 
 There were no differences in MPOD values during the second trimester between women 
supplementing with a DHA/fish oil containing prenatal (0.36 ± 0.18) versus those not 
supplementing with a DHA/fish oil prenatal (0.31 ± 0.16, p= 0.54).  However, there was a small 
trend (p=0.13) for MPOD of women who supplemented with a prenatal with  DHA/fish oil (0.41 
± 0.17) compared to MPOD of women who did not supplement with a prenatal with  DHA/fish 
oil (0.28 ± 0.20) to decrease in the third trimester.  
MPOD across pregnancy was positively correlated with dietary lutein +zeaxanthin (figure 
5), number of fruits and vegetables high in lutein + zeaxanthin (figure 6) and seafood servings 
per week (figure 7): lutein + zeaxanthin, (R²=0.15, p≤0.01), number of fruits and vegetables high 
in lutein + zeaxanthin (R²=0.05, p≤0.03), seafood servings per week (R²=0.17, p≤0.01).  MPOD 
was significantly correlated with seafood servings per week at 18-23 weeks (R²=0.33, p≤0.02) 
and at 36-38 weeks (R²=0.34, p≤0.02), but not at weeks 24-26 (R² 0.13=p≤0.15) and week 30 
(R²=0.11 p≤0.20) 
 






Figure 6. Positive relationship between MPOD and fruits (f) and vegetables (v) high in lutein (L) 
+ zeaxanthin (Z) 
 
 
Figure 7. Positive relationship between MPOD and seafood servings per week 
 
Discussion  
 The uniqueness of this study lies in the fact that MPOD was assessed across the late 
second and third trimester of pregnancy.  No other data on MPOD in pregnancy have been 
published to the best of our knowledge.  Results from the current study show that a woman‟s diet 




DHA intakes either remain consistently high or low during pregnancy. This finding supports the 
previous finding of others [70].   
 Expert groups recommend 300 mg/d of DHA for pregnant and lactating women [32]. 
This recommendation is based on research studies [14, 25-26] indicating the positive benefits of 
supplemental DHA to promote brain and retina development of the fetus.  In this study, average 
dietary DHA consumption for pregnant women was below expert group recommendations [32].  
This finding is surprising considering women participating in this study live in coastal Louisiana, 
where the incorporation of seafood is generally typical in the local cuisine.  However, evidence 
from this study indicates that average dietary DHA intakes (148 mg/d ±47mg) were similar to 
DHA intakes reported for women in both the U.S and Canada [6, 8, 71].  This finding has 
importance because maternal DHA intake and status is important to fetal retinal and brain 
development.  DHA oil is currently in many prenatal vitamins, either as DHA or fish oil and 
women in this study consuming these were therefore consuming on average 255 mg of DHA/fish 
oil/day via their supplements.  Thus, because dietary DHA intake was low for many women, our 
data lead us to suggest that pregnant women should be supplementing with a DHA prenatal to 
attain the recommended intake of DHA.  
 Results from the current study of a very small population of pregnant women showed that 
MPOD did not significantly decrease over the last trimester of pregnancy.  However, our data 
suggest that during the third trimester, women who supplemented with DHA/fish oil prenatals 
tended to have higher MPOD compared to women not supplementing. This finding leads us to 
suggest a prenatal supplement with DHA/fish oil during the third trimester is important to 
maintaining MPOD; a larger population needs to be studied to get a true picture of MPOD during 




time with a power of 80%, an alpha of 0.05, mean values of MPOD (0.36, 0.34, 0.36, 0.29) and a 
standard deviation of 0.19 at each time point, a larger sample size is required (n=121).   
This study did not capture pre-pregnancy lifestyle habits or the first to early second 
trimester of pregnancy.  The course of pregnancy measured in the current study (18-23 to 36-38 
weeks), may not have captured a large enough window in pregnancy to detect a change in 
MPOD.  A study of women from the beginning of pregnancy may shed new light on what is 
occurring.  It could be that DHA from the RPE were recycled back to the photoreceptors to help 
maintain the integrity of the retina and therefore MPOD.  The retina acts as a conservatory for 
DHA [49]. Photoreceptor outer segments (POS), which store DHA filled discs, are shed daily 
and accumulate in the retinal pigment epithelium (RPE).  This is in essence a conservation of  
DHA [49].  This mechanism may be particularly important during periods of low DHA intake 
and during pregnancy when DHA is being preferentially transported across the placenta to the 
developing fetus.  Thus, recycling of DHA may conserve the macula and MPOD. 
  Additionally, MPOD was associated by dietary lutein + zeaxanthin, the number of fruits 
and vegetables eaten high in lutein + zeaxanthin and seafood servings per week.  Dietary lutein + 
zeaxanthin are found in high amounts in foods such as, but not limited to: spinach, kale, corn, 
oranges, melons and egg yolks [41].  In our current study, pregnant women who consumed 
higher amounts of lutein + zeaxanthin had higher MPOD.  This result is underscored by findings 
previously reported for both males and females [5, 16].  Johnson et al [5], showed that elderly 
women supplementing with 12 mg/d of lutein for four months  had an increased MPOD.  
Likewise, Kopsell et al [16] showed that MPOD was higher among both males and females 




 Cho et al [15] showed that weekly fish consumption by elderly subjects (> 4 x per week) 
resulted in lower rates of age related macular degeneration compared to study participants who 
consumed fish less than 3 times per month.  Thus, the current study in pregnant women extends 
previous findings, documenting that dietary sources of lutein + zeaxanthin and DHA are 
important to eye health and specifically to macula health. 
This exploratory study provided useful data that can guide us in future studies of MPOD 
and diet during pregnancy.  Further studies can focus on the following: (i) evaluating MPOD 
during pregnancy with a larger sample size (n=121); (ii) Studying MPOD during the course of 
the entire pregnancy; and (iii) exploring the benefits of DHA/fish oil intervention on MPOD 

















CHAPTER 5  
CONCLUSION 
 
The purpose of this study was to explore MPOD during the course of pregnancy.  These 
exploratory data suggest that women consuming a prenatal supplement containing DHA/fish oil, 
during the third trimester tended to have a higher MPOD than those not supplementing and DHA 
intake among pregnant women is low in Louisiana.  Based on the data, a larger number of 
pregnant women are needed to determine if pregnancy and DHA/fish oil/fish intake modulate 
MPOD.   
The U.S Food and Drug Administration (FDA) recommend for women to consume 2-3 
servings of fish weekly encompassing an expert group recommendation of 300 mg/d of DHA 
during pregnancy.  Women are encouraged to eat fish weekly and to eat food high in lutein and 
zeaxanthin to protect macula health.  Pregnant women should be encouraged to increase their 
intake of dietary DHA to ensure an adequate DHA supply for both the mother and the infant.   
Furthermore, because dietary consumption of DHA was low for participants in this study, 
it is concluded that a prenatal supplement consisting of at least 200 mg of DHA should be 
supported and/or prescribed to ensure women are consuming the amount recommended to 
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APPENDIX A: HEALTH HISTORY AND DIETARY QUESTIONNAIRE FORMS 
Health History Form 
 
Name: _______________________       Code #: ________ 
Date: ________________________ 
Age: ________ 
Weight: _________ lbs. (to be completed by investigator) 
Height: _________ inches (to be completed by investigator) 
BMI: __________ (to be completed by investigator) 
1. Ethnicity (check one): 
 American Indian or Alaska Native 
 Asian 
 Black or African American 
 Native Hawaiian or Other Pacific Islander 
 White 
 Hispanic or Latino 
 Others (specify): ______________________ 







3. Do you have a family history of eye disease?  _______Yes ______ No  
  If yes, name disease if known ______________________________ 
 
4. Have you been diagnosed with eye disease?   ______ Yes  ______ No 
  If yes, name disease ______________________________________ 




6. Do you have high cholesterol or high blood pressure?   ______ Yes  _______No 
7. Do you have any other health conditions not mentioned above? (For example, have you 
been diagnosed with diabetes, hyper(hypo)thyroidism, heart disease, etc).   If yes, 
please list. 
_______ Yes   ______ No 
List:_____________________________________________ 
 
8. Do you smoke cigarettes, cigars or pipes?  _______ Yes ______ No 
  If yes, how many per day _______ per week ________ per month ________ 
 
9. Do you drink alcoholic beverages?  _______ Yes _______ No 
  If yes, how many per day _______ per week ________ per month ________ 
 
10. Do you use any nutritional supplements?  ______ Yes ______ No 
  If yes, which ones? (Include brand name if known)_________________________ 
 
11. Do you eat most of your meals away from home?  ______ Yes _______ No 
  If yes, where do you usually eat? _______________________________________ 
 
12. How many times do you eat fruits and vegetables? 
        _____ per week   
 (or) _____ per month     
 (or) _____ per year 
 









14. Below, please circle the fruits and vegetables that you eat: 
Kale      Brussels sprouts 
Turnip Greens    Green Beans 
Collards    Tangerines and tangerine juice 
Spinach    Oranges and orange juice 
Broccoli    Okra 
Corn     Celery 
Peas      Tomatoes and Tomato juice 
Romaine Lettuce (also called               Melons 
cos lettuce)        Peaches         
Carrots    Papayas 
 
15. How many times do you eat seafood (fresh, frozen or canned)? 
      _____ per week      
(or)_____per month    
(or) _____per year 
 







17. If you don’t consume fresh fruits and vegetables frequently what are the main reasons? 




 I don’t know how to prepare them 
 I don’t not buy my own groceries 
 I don’t like them 
 They don’t have long shelf life 
 Other:___________________ 
 
18. If you don’t consume seafood frequently what are the main reasons? 
 Too expensive 
 I don’t know how to prepare them 
 I don’t not buy my own groceries 
 I don’t like them 
 They don’t have long shelf life 
 Other:___________________ 
 
Health History Form #2 
 
Name: _______________________       Code #: ________ 
Date: ________________________ 
Age: ________ 
Weight: _________ lbs. (to be completed by investigator) 
BMI: __________ (to be completed by investigator) 
19. Have you been diagnosed with eye disease?   ______ Yes  ______ No 
  If yes, name disease ______________________________________ 





21. Have you been diagnosed with gestational diabetes mellitus?  _____Yes _____ No 
 
22. Do you have any other health conditions not mentioned above? (For example, have you 
been diagnosed with diabetes, hyper(hypo)thyroidism, heart disease, etc).   If yes, 
please list. 
_______ Yes   ______ No 
List:_____________________________________________ 
 
23. Do you smoke cigarettes, cigars or pipes?  _______ Yes ______ No 
  If yes, how many per day _______ per week ________ per month ________ 
 
24. Do you drink alcoholic beverages?  _______ Yes _______ No 
  If yes, how many per day _______ per week ________ per month ________ 
 
25. Do you use any nutritional supplements?  ______ Yes ______ No 
  If yes, which ones? (Include brand name if known)_________________________ 
 
26. Do you eat most of your meals away from home?  ______ Yes _______ No 
  If yes, where do you usually eat? _______________________________________ 
 
27. How many times do you eat fruits and vegetables? 
        _____ per week   
 (or) _____ per month     
 (or) _____ per year 
 









29. Below, please circle the fruits and vegetables that you eat: 
Kale      Brussels sprouts 
Turnip Greens    Green Beans 
Collards    Tangerines and tangerine juice 
Spinach    Oranges and orange juice 
Broccoli    Okra 
Corn     Celery 
Peas      Tomatoes and Tomato juice 
Romaine Lettuce (also called               Melons 
cos lettuce)        Peaches         
Carrots    Papayas 
 
30. How many times do you eat seafood (fresh, frozen or canned)? 
      _____ per week      
(or)_____per month    
(or) _____per year 
 
 










32. If you don’t consume fresh fruits and vegetables frequently what are the main reasons? 
 Too expensive 
 I don’t know how to prepare them 
 I don’t not buy my own groceries 
 I don’t like them 
 They don’t have long shelf life 
 Other:___________________ 
 
33. If you don’t consume seafood frequently what are the main reasons? 
 Too expensive 
 I don’t know how to prepare them 
 I don’t not buy my own groceries 
 I don’t like them 















APPENDIX B: FOOD SOURCES HIGH IN L&Z AND DHA 
Foods high in L: http://www.pbrc.edu/Division_of_Education/pdf/PNS_Lutein.pdf 
Food  Micrograms/ cup  Micrograms/100 g  
Kale  23720  18246  
Spinach  20354  11308  
Turnip greens  12154  8440  
Collards  14619  7694  
Mustard greens  8347  5962  
Parsley, raw  556  5560  
Dandelion greens  4944  4709  
Peas, green, frozen  3840  2400  
Lettuce, romaine, raw  1295  2313  
Summer squash  4048  2249  
Beet greens  2619  1819  
Lettuce, green leaf, raw  969  1730  
Broccoli  2367  1517  
Squash, winter  2901  1415  
Brussels sprouts  2012  1290  
Onions, spring or scallions, raw  1137  1137  
Corn, sweet, yellow, canned  2195  1045  
Pumpkin  2484  1014  
 
Fish High in DHA 
Fish Species and Description DHA per 100 g 
Crustaceans, crab, blue, cooked, moist heat 0.231 
Crustaceans, crab, queen, cooked, moist heat 0.145 
Fish, anchovy, European, raw 0.911 
Fish, anchovy, European, canned in oil, drained solids 1.292 





Fish Species and Description DHA per 100 g 
Fish, bass, striped, cooked, dry heat 0.750 
Fish, bluefish, cooked, dry heat  0.665 
Fish, catfish, channel, farmed, cooked, dry heat 0.128 
Fish, catfish, channel, wild, cooked, dry heat 0.137 
Fish, caviar, black and red, granular 3.800 
Fish, cod, Atlantic, cooked, dry heat 0.154 
Fish, cod, Pacific, cooked, dry heat 0.173 
Fish, drum, freshwater, cooked, dry heat 0.368 
Fish, flatfish (flounder and sole species), cooked, dry heat 0.258 
Fish, grouper, mixed species, cooked, dry heat 0.213 
Fish, halibut, Atlantic and Pacific, cooked, dry heat 0.374 
Fish, halibut, Greenland, cooked, dry heat 0.504 





Fish Species and Description DHA per 100 g 
Fish, herring, Atlantic, kippered 1.179 
Fish, herring, Pacific, cooked, dry heat 0.883 
Fish, lingcod, cooked, dry heat 0.130 
Fish, mackerel, Atlantic, cooked, dry heat 0.699 
Fish, mackerel, king, cooked, dry heat 0.227 
Fish, mackerel, Pacific and jack, mixed species, cooked, dry heat 1.195 
Fish, mackerel, Spanish, cooked, dry heat 0.952 
Fish, mullet, striped, cooked, dry heat  0.148 
Fish, ocean perch, Atlantic, cooked, dry heat 0.271 
Fish, perch, mixed species, cooked, dry heat 0.223 
Fish, pike, northern, cooked, dry heat 0.095 
Fish, pike, walleye, cooked, dry heat 0.288 





Fish Species and Description DHA per 100 g 
Fish, rockfish, Pacific, mixed species, cooked, dry heat 0.262 
Fish, roe, mixed species, cooked, dry heat 1.747 
Fish, roe, mixed species, raw 1.363 
Fish, sablefish, cooked, dry heat 0.920 
Fish, sablefish, smoked 0.945 
Fish, salmon, Atlantic, farmed, cooked, dry heat 1.457 
Fish, salmon, Atlantic, wild, cooked, dry heat 1.429 
Fish, salmon, Chinook, cooked, dry heat 0.727 
Fish, salmon, chum, cooked, dry heat  0.505 
Fish, salmon, chum, drained solids with bone 0.702 
Fish, salmon, coho, farmed, cooked, dry heat 0.871 
Fish, salmon, coho, wild, cooked, dry heat 0.658 





Fish Species and Description DHA per 100 g 
Fish, salmon, sockeye, cooked, dry heat 0.700 
Fish, sardine, Atlantic, canned in oil, drained solids with bone 0.509 
Fish, sea bass, mixed species, cooked, dry heat 0.556 
Fish, sea trout, mixed species, cooked, dry heat 0.265 
Fish, shad, American, raw 1.321 
Fish, shark, mixed species, raw 0.527 
Fish, smelt, rainbow, cooked, dry heat 0.536 
Fish, snapper, mixed species, cooked, dry heat 0.273 
Fish, spot, cooked, dry heat 0.526 
Fish, sucker, white, cooked, dry heat 0.371 
Fish, swordfish, cooked, dry heat 0.681 
Fish, tilefish, cooked, dry heat 0.733 





Fish Species and Description DHA per 100 g 
Fish, trout, rainbow, farmed, cooked, dry heat 0.820 
Fish, trout, rainbow, wild, cooked, dry heat 0.520 
Fish, tuna, fresh, bluefin, cooked, dry heat  1.141 
Fish, tuna, light, canned in oil, drained solids 0.101 
Fish, tuna, light, canned in water, drained solids 0.223 
Fish, tuna, skipjack, fresh, cooked, dry heat 0.237 
Fish, tuna, white, canned in water, drained solids 0.629 
Fish, tuna, yellowfin, fresh, cooked, dry heat 0.232 
Fish, whitefish, mixed species, cooked, dry heat 1.206 
Fish, whiting, mixed species, cooked, dry heat 0.235 
Fish, wolffish, Atlantic, cooked, dry heat 0.405 
Mollusks, mussel, blue, cooked, moist heat 0.506 





Fish Species and Description DHA per 100 g 
Mollusks, oyster, eastern, wild, cooked, dry heat 0.291 
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